- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03224520
Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions
Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
S2S has many innovations that are designed to utilize the power of peers and social networks for dissemination. These include: Peer recruitment: Tools to facilitate smokers' recruiting their peers to increase Decide2Quit access; and a recommender computer tailored health communication (recommender CTHC): a Complex machine learning algorithm (recommender systems) that uses smokers' feedback (explicit and implicit) in the current and prior studies to adapt its selection of messages to smokers.
Using a 2×2 factorial design, the study will compare individually and collectively the enhancements (recruitment, use, and effectiveness) offered by the S2S functions over the standard version of Decide2Quit (online recruitment and standard CTHC), an active comparison group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01605
- University of Massachusetts Medical School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years of Age or older
- Current smoker
Exclusion Criteria:
- Under 18 years of age
- Non-smoker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fully enhanced
Peer recruitment and recommender CTHC
|
Enhanced Messaging
Tools to facilitate smokers' recruiting their peers
|
|
Experimental: Recommender CTHC only
Recommender CTHC and standard online recruitment
|
Enhanced Messaging
Search Engine and Social Media Advertisements
|
|
Experimental: Peer recruitment only
Peer recruitment and standard CTHC
|
Tools to facilitate smokers' recruiting their peers
Standard Messaging
|
|
Experimental: Standard
Standard online recruitment and standard CTHC
|
Search Engine and Social Media Advertisements
Standard Messaging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smoking Cessation
Time Frame: At 6 months post registration
|
Smoking cessation measured by the 7-day point prevalence question: Six month, 7-day point prevalence : Do you currently smoke cigarettes (smoked even 1 puff in the last 7 days)?
|
At 6 months post registration
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Number of Cigarettes Smoked
Time Frame: At 6 months post registration
|
Calculated as: number of cigarettes smoked at six months minus the number of number of cigarettes smoked at baseline.
|
At 6 months post registration
|
|
Repeated Use of Decide2Quit Functions
Time Frame: Throughout study (tracked for 6 months post registration)
|
As measured by, an ordinal scale of number of Decide2Quit functions used after the first DISC visit (0: no functions used; 1: use of 1-2 functions, 2: > 2 functions used).
|
Throughout study (tracked for 6 months post registration)
|
|
Recruitment of African Americans
Time Frame: At Baseline Registration
|
This is measured by the proportion of African Americans in each treatment arm
|
At Baseline Registration
|
|
Recruitment Time
Time Frame: At Baseline Registration
|
Calculated as: each individual participant's recruitment date minus the date of the first participant's registration.
Based on this formula, the first participant will have a recruitment time of 0 days and the last participant could have a maximum recruitment time of 3 years (1095 days).
|
At Baseline Registration
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Rajani Sadasivam, PhD, University of Massachusetts, Worcester
Publications and helpful links
General Publications
- Chen J, Houston TK, Faro JM, Nagawa CS, Orvek EA, Blok AC, Allison JJ, Person SD, Smith BM, Sadasivam RS. Evaluating the use of a recommender system for selecting optimal messages for smoking cessation: patterns and effects of user-system engagement. BMC Public Health. 2021 Sep 26;21(1):1749. doi: 10.1186/s12889-021-11803-8.
- Faro JM, Nagawa CS, Orvek EA, Smith BM, Blok AC, Houston TK, Kamberi A, Allison JJ, Person SD, Sadasivam RS. Comparing recruitment strategies for a digital smoking cessation intervention: Technology-assisted peer recruitment, social media, ResearchMatch, and smokefree.gov. Contemp Clin Trials. 2021 Apr;103:106314. doi: 10.1016/j.cct.2021.106314. Epub 2021 Feb 8.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CDR-1603-34645
- CDR160334645 (Other Grant/Funding Number: Patient-Centered Outcomes Research Institute)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
The University of Hong KongCompletedSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
Clinical Trials on Recommender CTHC
-
University of Massachusetts, WorcesterCompletedSmoking CessationUnited States
-
Newcastle UniversityUniversity of Plymouth; Cornwall Partnership NHS Foundation TrustWithdrawn
-
Northwestern UniversityCompletedDepression | AnxietyUnited States
-
Tan Tock Seng HospitalMarquette University; Lee Kong Chian School of Medicine, Nanyang Technological...Not yet recruiting
-
Luxembourg Institute of HealthEuropean CommissionRecruiting
-
ResMedNot yet recruiting
-
Northwestern UniversityNational Institute of Mental Health (NIMH)CompletedDepression - Major Depressive DisorderUnited States